A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/17062687

Clin. Cancer Res. 2006 Oct 15 12 20 Pt 1 6106-15

Download in:

View as

Triples

General Info

PMID
17062687